These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16381847)

  • 1. The REFOLD database: a tool for the optimization of protein expression and refolding.
    Chow MK; Amin AA; Fulton KF; Fernando T; Kamau L; Batty C; Louca M; Ho S; Whisstock JC; Bottomley SP; Buckle AM
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D207-12. PubMed ID: 16381847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REFOLD: an analytical database of protein refolding methods.
    Chow MK; Amin AA; Fulton KF; Whisstock JC; Buckle AM; Bottomley SP
    Protein Expr Purif; 2006 Mar; 46(1):166-71. PubMed ID: 16150607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refolding your protein with a little help from REFOLD.
    Phan J; Yamout N; Schmidberger J; Bottomley SP; Buckle AM
    Methods Mol Biol; 2011; 752():45-57. PubMed ID: 21713630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. REFOLDdb: a new and sustainable gateway to experimental protocols for protein refolding.
    Mizutani H; Sugawara H; Buckle AM; Sangawa T; Miyazono KI; Ohtsuka J; Nagata K; Shojima T; Nosaki S; Xu Y; Wang D; Hu X; Tanokura M; Yura K
    BMC Struct Biol; 2017 Apr; 17(1):4. PubMed ID: 28438161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PFD: a database for the investigation of protein folding kinetics and stability.
    Fulton KF; Devlin GL; Jodun RA; Silvestri L; Bottomley SP; Fersht AR; Buckle AM
    Nucleic Acids Res; 2005 Jan; 33(Database issue):D279-83. PubMed ID: 15608196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative refolding of recombinant prochymosin.
    Wei C; Tang B; Zhang Y; Yang K
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):345-51. PubMed ID: 10229691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro refolding of heterodimeric CapZ expressed in E. coli as inclusion body protein.
    Remmert K; Vullhorst D; Hinssen H
    Protein Expr Purif; 2000 Feb; 18(1):11-9. PubMed ID: 10648164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adsorptive refolding of a highly disulfide-bonded inclusion body protein using anion-exchange chromatography.
    Chen Y; Leong SS
    J Chromatogr A; 2009 Jun; 1216(24):4877-86. PubMed ID: 19419725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refolding and simultaneous purification of recombinant human proinsulin from inclusion bodies on protein-folding liquid-chromatography columns.
    Yuan J; Zhou H; Yang Y; Li W; Wan Y; Wang L
    Biomed Chromatogr; 2015 May; 29(5):777-82. PubMed ID: 25378200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confronting high-throughput protein refolding using high pressure and solution screens.
    Qoronfleh MW; Hesterberg LK; Seefeldt MB
    Protein Expr Purif; 2007 Oct; 55(2):209-24. PubMed ID: 17681810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-pressure refolding of human vascular endothelial growth factor (VEGF) recombinantly expressed in bacterial inclusion bodies: refolding optimization, and feasibility assessment.
    Cothran A; St John RJ; Schmelzer CH; Pizarro SA
    Biotechnol Prog; 2011; 27(5):1273-81. PubMed ID: 21608142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting protein refolding yields in a fed-batch and batch-refolding system.
    Mannall GJ; Titchener-Hooker NJ; Dalby PA
    Biotechnol Bioeng; 2007 Aug; 97(6):1523-34. PubMed ID: 17304557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the design-of-experiments approach for the development of a refolding technology for progenipoietin-1, a recombinant human cytokine fusion protein from Escherichia coli inclusion bodies.
    Boyle DM; Buckley JJ; Johnson GV; Rathore A; Gustafson ME
    Biotechnol Appl Biochem; 2009 Jul; 54(2):85-92. PubMed ID: 19435462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic optimization of expression and refolding of the Plasmodium falciparum cysteine protease falcipain-2.
    Sijwali PS; Brinen LS; Rosenthal PJ
    Protein Expr Purif; 2001 Jun; 22(1):128-34. PubMed ID: 11388810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clarification and capture of high-concentration refold pools for E. coli-based therapeutics using expanded bed adsorption chromatography.
    Xu X; Hirpara J; Epting K; Jin M; Ghose S; Rieble S; Li ZJ
    Biotechnol Prog; 2014; 30(1):113-23. PubMed ID: 24167114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in in vitro refolding of inclusion body proteins].
    Fang M; Huang HL
    Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):608-12. PubMed ID: 11910749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technical refolding of proteins: Do we have freedom to operate?
    Eiberle MK; Jungbauer A
    Biotechnol J; 2010 Jun; 5(6):547-59. PubMed ID: 20518058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical applications of hydrostatic pressure to refold proteins from inclusion bodies for NMR structural studies.
    Ogura K; Kobashigawa Y; Saio T; Kumeta H; Torikai S; Inagaki F
    Protein Eng Des Sel; 2013 Jun; 26(6):409-16. PubMed ID: 23525046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renaturation of the catalytic domain of PDE4A expressed in Escherichia coli as inclusion bodies.
    Richter W; Hermsdorf T; Dettmer D
    Methods Mol Biol; 2005; 307():155-65. PubMed ID: 15988062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian G protein-coupled receptor expression in Escherichia coli: II. Refolding and biophysical characterization of mouse cannabinoid receptor 1 and human parathyroid hormone receptor 1.
    Michalke K; Huyghe C; Lichière J; Gravière ME; Siponen M; Sciara G; Lepaul I; Wagner R; Magg C; Rudolph R; Cambillau C; Desmyter A
    Anal Biochem; 2010 Jun; 401(1):74-80. PubMed ID: 20175983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.